Evaluation of ticagrelor pharmacodynamic interactions with reversibly binding or non-reversibly binding P2Y12 antagonists in an ex-vivo canine model
Keywords: آدنوزین دی فسفات; ACS, acute coronary syndromes; ADP, adenosine diphosphate; AU, aggregation units; AUC0−∞, area under the plasma concentration-time curve from zero to infinity; AUC0−t, area under the plasma concentration-time curve from zero to last measurable time point;